Kingsview Wealth Management LLC lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 22.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,299 shares of the company’s stock after purchasing an additional 1,152 shares during the […]
Vanguard Personalized Indexing Management LLC lifted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 61,218 shares of the company’s stock after buying an additional 3,010 shares during the […]
Tealwood Asset Management Inc. decreased its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,402 shares of the company’s stock after selling 413 shares during the period. […]
Oppenheimer Asset Management Inc. grew its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 46.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 72,862 shares of the company’s stock after acquiring an additional 22,977 shares during the quarter. Oppenheimer Asset Management Inc.’s […]
Milestone Investment Advisors LLC bought a new stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 1,000 shares of the company’s stock, valued at approximately $68,000. A number of other institutional investors have also modified […]